Shreya Bhandari; Hasmitha Kamineni. Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 Receptors in Breast Cancer Patients. Int. j. res. appl. sci. biotechnol. 2021, 8, 104-109.